RPR (Dx) w/Refl Titer: What Non-Reactive and Reactive Mean on a Syphilis Screen

At a Glance

This test looks for antibodies your body makes during a syphilis infection — not for the bacterium itself. RPR stands for rapid plasma reagin. Reagin is a group of antibodies produced when tissue is damaged during a syphilis infection, and in a number of unrelated conditions too. The screening step asks only whether they are there at all, which is why it comes back as a word; the titer that follows a reactive screen puts a number on them.

Your result is one word: Non-Reactive or Reactive. Non-reactive is what both reference laboratories print as the expected value. Some reports say weakly reactive — read that with the Reactive row below; it still triggers the follow-on tests.

There are two versions of this test, ordered for opposite reasons. The distinction is printed on your report, and it changes both what your result means and what runs next:

"w/Refl" means with reflex: the follow-on tests run automatically, and a non-reactive result reflexes to nothing. The treponemal test in the diagnostic cascade looks for antibodies to the bacterium itself, and is there because a reactive RPR alone is not a diagnosis.

A titer is a dilution, and only large changes mean anything. A titer of 1:16 means the sample still reacted when diluted sixteenfold. The CDC's rule: a fourfold change — two dilutions, such as 1:16 to 1:4 — is what counts as a clinically meaningful difference between two results. One dilution is not enough on its own to show a real change, which is not the same as showing nothing changed.

Titers from different test types are not comparable, and different laboratories are best treated the same way. The CDC states that titers from RPR, VDRL and other nontreponemal tests "should not be used interchangeably... because they are different test methods." If you are tracking results, compare from one laboratory and one test type.

A non-reactive result can occur early in an infection, before antibodies are detectable. Syphilis has "an incubation period of 10-90 days" before the first sore appears, and antibodies take time to develop. Labcorp's instruction on its traditional-algorithm panel is direct: "If recent exposure is suspected, submit a new sample for testing in 2-4 weeks."

The screen is not a perfect net even after that, and published estimates of how good it is disagree. Compared with direct microscopy of a sore, RPR sensitivity in primary syphilis "ranged from 48.7% to 76.1%" across the studies the CDC groups together — "however, one study reported a sensitivity of 92.7%". Sensitivity declines in longer-standing infection, though the CDC notes "no studies involving RPR test performance for latent syphilis have been conducted in the United States". The prozone phenomenon can also cause a false negative when antibody levels are very high; it "can be avoided if the serum sample is diluted before testing."

None of this makes a non-reactive result meaningless. It answers the question did this test find reagin antibodies today. A suspected exposure or symptoms are reasons to ask your clinician about testing again.

Why there is no number to compare against. RPR is not measured on a scale — LOINC classifies it as an ordinal result, and the expected value both reference laboratories publish is the single word Non-Reactive. The tracker compares your word against that expected word rather than plotting a figure.

How to read your result

Which row applies depends on which version you had — your report says which.

One exception to reading the false-positive causes casually. In pregnancy a reactive screen is followed up rather than set aside, because untreated syphilis can pass to the baby — a conversation for this week, not next month.

If you remember only one thing

Non-reactive is the expected result; reactive is a signal rather than a diagnosis. On the diagnostic panel a reactive RPR triggers a treponemal test precisely because the screen alone cannot separate syphilis from the unrelated conditions producing the same antibodies. A reactive screen with no confirming line yet is a question, not an answer.

Two people, same result

Two people both open a report that says Non-Reactive.

The first was screened for the first time — routine panel, no symptoms. Her RPR is non-reactive and nothing reflexes: no serological evidence of syphilis on the day of the draw.

The second was treated eight months ago, when his RPR was 1:32. It is now non-reactive. For him this was never a screen: what matters is the distance travelled from 1:32 and how long it took — a judgement his clinician makes, not one the single word supports alone. His treponemal test, run at diagnosis, is still reactive and will likely stay so: the CDC notes that "the majority of patients who have reactive treponemal tests will have reactive tests for the remainder of their lives, regardless of adequate treatment or disease activity."

The third was screened on the diagnostic panel and opened a report saying Reactive and nothing else. Her titer and treponemal test are running on the same tube. Until that treponemal result arrives, Reactive alone does not separate syphilis from the unrelated conditions producing the same antibodies.

Three different findings — because the version of the test, the reason it was ordered, and which lines have reported yet are what give the words their meaning.

What this result cannot tell you

When an infection was acquired. The screen reports whether reagin antibodies are present now, not for how long.

Whether an infection is too recent to show. Serology can be non-reactive early on.

Whether a reactive result is syphilis. The treponemal test in the diagnostic cascade is what settles that. Reagin antibodies also arise in other infections including HIV, in autoimmune conditions, after vaccination, with injecting drug use, in pregnancy and with older age.

Whether a reactive pair is past or present infection. Either; your history decides.

Whether a past infection was treated adequately. That needs the pre-treatment titer, the interval since treatment and the stage — none of which is on this line.

What your titer means against someone else's. Different laboratories and methods do not produce interchangeable titers.

Whether an infection has reached the nervous system or the eyes. A different specimen and different tests answer that.

Common interpretation mistakes

Reading a reactive screen as a diagnosis. The confirmation carries it.

Comparing a titer across laboratories or test types. They are not interchangeable.

Treating a one-dilution change as progress or relapse. Fourfold is the threshold.

Expecting a treponemal test to turn negative after treatment. It ordinarily does not; a reactive one years later is not evidence of failure.

Looking for a number to compare against. This test does not produce one; the word is the result.

Assuming the monitoring version rules out a new infection. Its laboratory states it should not be used for screening, and it runs no confirmatory test.

Questions your doctor may ask

• Which version was ordered — diagnosis or monitoring?
• Have you had a reactive syphilis test before, and do you know the titer?
• Have you been treated for syphilis, and when?
• Any possible recent exposure? Any symptoms — a painless sore, a rash including palms or soles, swollen glands?
• Are you pregnant, or do you have HIV or an autoimmune condition?
• Any earlier results from the same laboratory to compare against?

Read together with

• RPR titer — the quantitative result reflexed from a reactive screen.
• Treponema pallidum antibodies — the confirming test in that cascade.
• HIV screening — tested alongside, and a cause of false positives.
• Hepatitis B and C serology — same profile.

Clinical pearls

The reflex chain is the point of the diagnostic panel. Screen, then titer, then treponemal confirmation, on one sample, without a second draw. It exists because the screen casts a wide net rather than a syphilis-specific one: good at flagging samples worth confirming, weaker in the earliest days and in long-standing infection, and unable to separate syphilis from the unrelated causes on its own. The monitoring version has no confirmatory step — it reflexes to a titer and stops.

The diagnostic panel runs the traditional algorithm — nontreponemal screen first, treponemal confirmation second. The reverse sequence algorithm starts with the treponemal immunoassay instead; the CDC treats both as acceptable, the choice driven by "laboratory resources... test volume, and patient populations served."

Some titers never disappear, and that has a name. After treatment, antibodies "might decrease less than fourfold... or might decline appropriately but fail to serorevert and persist for a long period." A titer settling at 1:1 or 1:2 and staying there is the serofast state — a recognized outcome, not automatic evidence of treatment failure.

Clinical Takeaway

RPR is a nontreponemal screen — detecting reagin rather than the bacterium — reported as Non-Reactive or Reactive with no numeric expected value. A reactive result reflexes to a quantitative titer, and on the diagnostic version to a treponemal confirmatory assay as well; the monitoring version has no confirmatory step. Interpretation depends on which version was ordered and on the pre-treatment titer where one exists. A fourfold change is the threshold for clinical significance, titers from different methods or laboratories are not interchangeable, treponemal reactivity persists for life in the majority of patients, and screen sensitivity is incomplete in primary syphilis.

In one sentence

Non-reactive is the expected result on this syphilis screen; a reactive result reflexes to a titer, and on the diagnostic version to a confirmatory treponemal test as well, so what either word means depends on whether the test was ordered to diagnose or to monitor.

Bottom line

If your report says Non-Reactive, that is the expected result, and no further test reflexes from it automatically. That describes the laboratory's process rather than settling the question about you: a suspected recent exposure, or symptoms, are reasons your clinician may want another test.

If it says Reactive on the diagnostic panel, a titer and a treponemal test are already running on the same sample; the treponemal result separates syphilis from the unrelated causes, though even a reactive pair supports past or current infection. If you are being monitored, watch the titer rather than the word: a fourfold move is the CDC's threshold for a clinically significant difference, and a smaller one is not enough on its own to establish a change.

RPR (DX) W/Refl Titer and Confirmatory Non-Reactive Testing

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →

Beyond RPR (DX) W/Refl Titer and Confirmatory Non-Reactive Testing — 10,000+ markers explained

One RPR (DX) W/Refl Titer and Confirmatory Non-Reactive Testing result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.

Start with this report →

Frequently Asked Questions